October 01, 2018
A New York federal judge has dismissed a pediatrician's kickback claims against MedImmune Inc., saying she couldn't allege False Claims Act violations that were a "virtual copy" of those first made by the state of New York.
January 23, 2018
An AstraZeneca unit facing kickback allegations over the infant respiratory drug Synagis told a New York federal court Monday that the patient information it provided to a Walgreens-owned home health care company doesn't count as an illegal kickback meant to boost Medicaid billings.
April 03, 2017
The AstraZeneca subsidiary MedImmune ripped off the government by teaming up with a specialty pharmacy to aggressively pursue sensitive patient information and increase sales of the infant lung drug Synagis, the New York attorney general told a federal court in the state Friday.
July 10, 2015
The New York Attorney General announced Friday that Walgreen Co. will pay $22.4 million to end an investigation spurred on by a whistleblower complaint that a company subsidiary was charging Medicaid for an expensive but unnecessary pediatric drug.